PHARMINE deliverable DMNGT1 0210

PHARMINE
Monthly managerial report February 2010
B. Rombaut and J. Atkinson.
C o o r d in a t o r : B a r t Ro m b a u t , S c h o o l o f Ph a r m a c y , V r ij e U n iv e r s it e it B r u s s e l,
B r u s s e ls , B e lg iu m . b r o m b a u t @ v u b . a c . b e
Ex e c u t iv e D ir e c t o r : J e f f A t k in s o n , Ph a r m a c o lo r C o n s u lt a n t s N a n c y , V ille r s , F r a n c e .
j e f f r e y . a t k in s o n @ o r a n g e . f r
W it h t h e s u p p o r t o f t h e L if e lo n g L e a r n in g P r o g r a m m e o f t h e E u r o p e a n U n io n
( 1 4 2 0 7 8 - L L P- 1 - 2 0 0 8 - B E- ERA S M U S - EC D S P) .
.
The following matters were dealt with in February 2010:
WP1 MNGT
1. Further calles for spoànsors i
2. Documents and publica9ons from ERASMUS mee9ng 2/2010 ii
3. Comments on progress report to EACEAiii
WP2 DISS
1. Website modifica9ons iv
2. SPML mee9ng Grenada Septemeber 2010 v
WP3 EXP
WP4 EXP
1. EAHP president posi9on vi
WP5 EXP
1. Reflexions on Bologna and other maOers vii
2. Invita9on to EIPG GA, May 2010viii
3. Recommenda9ons PHARMINE VUB / EIPGix
WPs 3, 4 and 5
WP6 QPLN
1. Prepara9on of Lisbon March 2010 mee9ngx
2. Country surveyxi
WP7 DEV
1. UKxii
2. Francexiii
3. Estonia xiv 4.
2
i -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet le-er from BMS 130210
: Date :Sat, 13 Feb 2010 18:06:14 +0100
De : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Pour : Rombaut Bart <[email protected]>, Lea Noel <[email protected]>
Dear Bart,
BMS have refused to help us - but at least they were polite and answered.
Perhaps Lea should keep all the proof of the letters sent out and the
answers received. So far we have 2 (negative) answers (Servier and BMS).
Is that right?
Best regards,
Jeff
13/02/2010 18:05
ii -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : ERASMUS COORDINATORS MEETING EACEA in Brussels on February 2-­‐3, 2010
Date : Thu, 18 Feb 2010 15:32:05 +0100
De : Lea Noel <[email protected]>
Pour : <[email protected]>, <'[email protected]'>, <'jagmorais@ff.ul.pt'>, <[email protected]>, <[email protected]>, <[email protected]>, <[email protected]>, <'benitodelcas][email protected]'>, "'Jeffrey ATKINSON'" <Jeff[email protected]­‐nancy.fr>
Copie 'Bart Rombaut' <[email protected]>
à : Dear Pharmine partner,
Kindly notice the latest EACEA rules for LLP projects as explained on the
recent Erasmus Coordinators meeting
1) a cancellation insurance is strongly advised for each trip as non used
travel tickets are not refunded
2) conversion rates are those valid at the start of the project, see the
euro exchange rates in annex
3) the REAL staff cost must be declared even if they exceed a ceiling - the
agency has the right to claim the pay slip
4) cooperating students must be paid and we have to declare their payment
-> we need proof from EPSA that they pay their staff (level = assistant)
5) bank interests (if any) must be declared
6) time sheets must be made quarterly
-> please send them in for the last quarter of 2009
7) the rent of meeting rooms must be declared in the section ‘other costs’
-> PGEU please send your notes, we can declare this as “own
resources”
Kind regards and many thanks
Text Box:
Lea NOËL, project assistant
VRIJE UNIVERSITEIT BRUSSEL
Faculteit Geneeskunde & Farmacie - MICH
Laarbeeklaan 103
B-1090 BRUSSELS
.
iii -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Date : Tue, 16 Feb 2010 16:00:16 +0100
De : Lea Noel <[email protected]>
Pour : <[email protected]>, <'[email protected]'>, <'jagmorais@ff.ul.pt'>, <[email protected]>, <[email protected]>, <[email protected]>, <[email protected]>, <'benitodelcas][email protected]'>, <[email protected]>
Copie 'Bart Rombaut' <[email protected]>, 'Jeffrey ATKINSON' <Jeff[email protected]­‐nancy.fr>
à : Dear Pharmine partners,
For your information, I am sending in attach the remarks and scores on the
1st year Progress Report.
With kind regards,
Lea
Approval of progress report
LeOer from Ralf Rahders, 1/12/2009
The progress report of PHARMINE (12 month) was read by an external expert who -­‐ as judged from the per9nence of his remarks -­‐ read and studied the report in detail.
The overall score was 7/10 “good – addresses the criteria with some aspects of high quality”.
Posi9ve points:
1. The (increasing) number of par9cipa9ng HEIs
2. Fast evolving field with harmoniza9on of educa9on a major issue
Nega9ve points:
1. Conflict of interest: the consor9um includes the 3 major representa9ves of community, hospital and industrial pharmacists and each of these has its own vested interests. This cal slow down or stop the process of agreement on harmoniza9on.
2. The budget recording should be accurate with concordance between ac9vi9es reported and persons reimbursed (travel and hotel expenses).
Criteria:
1. Objec9ves, results, products (score 8/10)
a. Coherent b. There is an overall delay due to lateness of WP7 survey
c. Produc9on so far
i. Website
ii. Leaflet
iii. Incorpora9on of new partners
2. Coherence between workplan and ac9vi9es (6/10)
a. Delay for WP7
b. Conflict of interest for P6, 7 and 8.
3. Is the partnership working (7/10)
a. P1 and 9 manage but others are sharing responsibili9es
b. Addi9onal partners: denotes strong will to produce representa9ve results. Will have to iden9fy specific roles of partners (no Potemkims)
4. Management (8/10)
a. Sa9sfactory
b. Problem of parallel funding
4
iv -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet FW: EIPG Journal Feb 2010 edi]on
: Date :Sun, 21 Feb 2010 13:58:32 -­‐0000
De : jane <[email protected]>
Pour : 'Jeffrey ATKINSON' <Jeff[email protected]­‐nancy.fr>
Please find attached the latest issue of our EIPG e-Journal. Please pass to
other members of your ExCo or add to your website if you feel appropriate.
Regards
Jane
Jane Nicholson BPharm.FRPharm.S.FTOPRA
Executive Director EIPG
-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet A couple of modifica]ons to the pharmine website
: Date :Fri, 19 Feb 2010 14:54:20 +0100
De : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Pour : Jorg Maniewski <[email protected]>
Dear Jorg,
A couple of modifications to the pharmine website
Many thanks,
Jeff Atkinson
5
v -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet Fw: CONGRES S.P.M.L 2010
: Date :Sat, 20 Feb 2010 19:13:11 +0100
De : Renée chambon <[email protected]>
Pour : Jeff ATKINSON <jeff[email protected]­‐nancy.fr>
Dear colleague,
I sent this message to Bart Rombaut and Carlo Rossi about 2 months ago
as new president and VP of the EAFP and they did not give me an answer .
I wonder whether you got it too?
Indeed I got a short message from you on Dec.18th saying that you would
like to participate in the September congress in Granada. Now things are
in progress and Granada has prepared a Preliminary Programme which I
would be glad to send over to you, but for that I need your address : could you
please
send it over to me ?
I would also like to know what you intend to put in your presentation(in french)
for the round table on "Les programmes d'échanges universitaires
en pharmacie,hier et aujourd'hui" to take place on Friday 17 September afternoon ?
I must add that there will also be a presentation from Italy and one from Spain
on the same subject and then discussion.I don't know the exact time available
for each presentation but I guess it must be between 20 and 30 minutes.
Now from a practical point of view let me tell you that both your flight and hotel
would be paid by the society.
I look forward to hearing from you at your earliest convenience.
Best wishes .
Renée Chambon
----- Original Message ----From: Renée chambon
To: Bart Rombaut
Cc: Carlo Rossi
Sent: Wednesday, December 09, 2009 10:45 PM
Subject: CONGRES S.P.M.L 2010
Chers collègues Présidents,
Comme vous le savez, j'ai dû quitter l'ExCo de l'EAFP suite à mon départ de
l'université de Lyon.
Néanmoins, je suis toujours avec intérêt les travaux de l'EAFP et j'ai noté avec
satisfaction que
le projet PHARMINE avait été reconnu par l'UE.
Par ailleurs je suis engagée dans le bureau de la SPML, Société de Pharmacie de la
Méditerranée Latine, qui depuis plus de 50 ans réunit des universitaires et des
professionnels de la
pharmacie de trois pays, l'Italie, l'Espagne et la France.
Or , il se trouve que le 29ème congrès international de la SPML doit se dérouler à
Granada (E)
du 15 au 18 Septembre 2010 (cf. site web <www.farmacia.ugr.es/sfml> ) et nous
recherchons un
conférencier français ou francophone pour la table ronde consacrée aux programmes
d'échanges universitaires hier et aujourd'hui. Les deux autres pays (Italie et
Espagne) se chargent
respectivement de trouver un intervenant.
N'étant plus dans le circuit universitaire, je me suis permis de faire appel à vous et
je vous remercie
d'avance de l'aide que vous pourrez m'apporter.
Dans l'attente ,recevez mes meilleures et confraternelles salutations.
Renée Chambon
6
vi -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Date : Wed, 10 Feb 2010 20:37:47 +0100
De : <[email protected]>
Pour : <[email protected]>, <jeff[email protected]­‐nancy.fr>
Copie <[email protected]>, <[email protected]>
à : Dear Bart, dear Jeffrey,
as promised I summarized my comments during the PHARMINE meeting in Brussels
in a statement, I attach
Please notice that the most comments are personal and not official statement
by EAHP as we did not discuss this in the board yet.
Best regards
Dr. Roberto Frontini
President EAHP
EAHP COMMENTS TO PHARMINE MEETING BRUSSELS JANUARY 7TH 2010
A t t e n d e d b y D r . Ro b e r t o Fr o n t in i, Pr e s id e n t an d D r . Ju r aj Sy k o r a, D ir e c t o r o f
Pr o f e s s io n al
D e v e lo p m e n t
EA HP s u g g e s t s t h at t h e Ph ar m in e Pr o g r e s s Re p o r t , D e c e m b e r 2 0 0 9 , A p p e n d ix 2 .
D r af t
Fo u n d at io n L e v e l Fr am e w o r k s h o u ld als o in c lu d e at le as t f o llo w in g c o m p o n e n t s :
a) Ph ar m ac e u t ic al c o m p o u n d in g :
T e c h n o lo g y o f c o m p o u n d in g , f o r m u lat io n an d p r o d u c t io n o f s t e r ile an d n o t s t e r ile
m e d ic in e s . Qu alit y m an ag e m e n t an d c o n t r o l
b ) A s p e c t s o f m e d ic al d e v ic e s u s e in t h e s am e m an n e r as m e d ic in e s .
Personal remarks
W h ile I ap p r e c iat e t h e e x c e lle n t c lar ifl c at io n o n c o m p e t e n c e an d c o m p e t e n c y b y
Pr o f . Ian
Bat e s , as h o s p it al p h ar m ac is t I w o u ld lik e t o u n d e r lin e f r o m a p r o f e s s io n al p o in t o f
v ie w s o m e
im p o r t an t as p e c t s o f t e r m in o lo g y an d c lar if y t h e n e e d s w e h av e in t h e h o s p it al
” e n v ir o n m e n t ‘ .
Fo u n d at io n le v e l is t h e le v e l n e c e s s ar y t o w o r k as p h ar m ac is t af t e r g r ad u at io n
( u n iv e r s it y
d e g r e e ) an d lic e n c e ( au t h o r is at io n t o w o r k as r e g u lat e d p r o f e s s io n al) b u t w e all
ag r e e t h at
ad v an c e d c o m p e t e n c y is n e c e s s ar y t o p e r f o r m w e ll in t h e m o r e c o m p le x r e alit y o f
p at ie n t c ar e
an d p r o d u c t io n o f m e d ic in e s .
T h e r e ar e t w o im p o r t an t as p e c t s :
a) Co n t e n t o f ad v an c e d c o m p e t e n c y ( k n o w le d g e an d s k ills )
b ) Se t t in g ( e n v ir o n m e n t , s e c t o r ) in w h ic h t h e y o u n g p r o f e s s io n al w ill u s e t h e
t r ain e d
com pet ency
As the scope of education is to prepare the pharmacist to be a competent professional
in patient care and production of medicines in praxis it is in my opinion not purposeful
to separate content from setting.
T h e r e ar e t h r e e m aj o r s e t t in g s ( s e c t o r s ) p h ar m ac is t s ar e w o r k in g in :
7
vii Jeffrey
Thanks for your e mail. I am aware of Finland, Sweden and Norway but what
other countries in Europe have a 3 year batchelor graduate who has a defined
place working in pharmacy?
Do not each of these countries have entry criteria which are lower than the
MPharm 5 year course? And hence are different graduates than those in
countries where there is an exit degree after 3 years of a 5 year course?
In the UK, practical experience in a pharmacy is started in the first year
of most of our UK courses, proceeding in years 2 and 3 to one to two weeks,
usually in a hospital pharmacy. This does not count towards the 12 month
pre-registration period but is a requirement of the university ( For first
hand student experience with patients.) The pre-reg year is currently under
the RPSGB but will move to the General Pharmaceutical Council ( the
government) until there is an integrated 5 year course in GB- which may not
happen in the current economic climate.
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Re: FW: PHARMINE Sorbonne, Bologna and other ma-ers
Date : Mon, 01 Feb 2010 11:24:06 +0100
De : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Pour : jane <[email protected]>
Copie à : 'Bart Rombaut' <[email protected]>
Références <E1NbCnm-­‐0005C8-­‐RP@pih-­‐relay05.plus.net>
: Dear Jane,
These questions are at the basis of the PHARMINE bid and have been from
the start.
It is a pity in fact that the declaration is called "Bologna" as it
really goes back to the Sorbonne. In those (earlier) discussions in
Paris (taken up in Bologna) the primordial issue was the "BMD" division
of university courses into 3 years bachelor, 2 years master and 3 years
Ph.D. In some countries one speaks of "3-5-8" (/trois-cinq-huit/) rather
than "Bologna". The whole issue then - and more so now - was what is to
be done with short university courses i.e. bachelors?
So obviously many countries have a 3-year degree in their pharmacy
faculty and WP7 has been looking at this in detail from the start.
A very good example is Finland. I sent the WP7 survey for Finland to all
PHARMINE partners several months ago (it is also on the PHARMINE website
now).
Regarding the pre-registration training a pattern is merging quite
clearly. A large number of EU countries start training early - in the
second or third year. EPSA is very much in favour of this. HEIs train
their students throughout their time at university. Thus the HEI - not
the professional body - organises, accredits and validates the training.
The professional body accepts the university validation of training.
This way of doing things is hinted at in directive 2005/36 but will have
to be clarified in the 2012 directive.
A secondary matter: still no news from the UK on WP7. This is a pity as
I am now in possession of full documentation from all EU member states
except the UK and Spain. As the UK has a rather special system compared
to other EU countries, this is unfortunate.
Best regards,
Jeff
01/02/2010 11:17
_____________________________________________________
8
viii -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Re: EIPG General Assembly15-­‐16th May 2010
Date : Thu, 18 Feb 2010 09:46:04 +0100
De : Bart Rombaut <[email protected]>
Pour : jane <[email protected]>, 'Jeffrey ATKINSON' <Jeff[email protected]­‐nancy.fr>
Références <E1NhmFR-­‐00032C-­‐[email protected]>
: Dear Jane,
Thank you for the invitation. I will be present in Milano.
arrive on friday and return on sunday ?
Yours sincerely,
Bart
Can I
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Re: EIPG General Assembly15-­‐16th May 2010
Date : Wed, 17 Feb 2010 19:01:39 +0100
De : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Pour : jane <[email protected]>
Copie à : Rombaut Bart <[email protected]>
Références <E1NhmFR-­‐00032C-­‐[email protected]>
: Sorry Jane but I am booked for a conference in Spain on those dates.
As Bart is running WP5, it would probably be more appropraite that he
goes anway?
Best regards,
Jeff
17/02/2010 19:01
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet EIPG General Assembly15-­‐16th May 2010
: Date :Wed, 17 Feb 2010 15:55:21 -­‐0000
De : jane <[email protected]>
Pour : 'Jeffrey ATKINSON' <Jeff[email protected]­‐nancy.fr>, Rombaut Bart <[email protected]>
Jeffrey and BartI am writing prior to Italy's formal invitation to ask if one of you could
join us again at our General Assembly on Saturday 15th May and help lead a
discussion on PHARMINE WP 5 during the afternoon.
I have just received confirmation from Jean-Pierre Paccioni that Prof Pierre
Tchoreloff will attend for the discussions on education.
Accommodation and GA will be in the Enterprise Hotel, Corso Sempione, 91,
20149, Milano, 30- 45 minutes from Linate or Malpensa airports.
Piero Iamartino will arrange shuttles from the airports to the hotel once
participants advise flight times.
Look forward to hearing from you
Jane
9
ix -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Working Party 5
Date : Thu, 25 Feb 2010 00:41:12 -­‐0000
De : jane <[email protected]>
Pour : 'Bart Rombaut' <[email protected]>
Copie 'Jeffrey ATKINSON' <Jeff[email protected]­‐nancy.fr>
à : To date, I have heard from 8 of the EIPG delegations regarding the
competency list, Denmark, Germany, Sweden, Malta, Latvia, Greece, Italy, GB.
There have been no major objections to date and a composite revision is
attached. I am chasing the other delegations that have yet to respond.
Regards
Jane
Knowledge Competencies needed by the Pharmacist for a career in the Pharmaceutical Industry
General: K n o w le d g e r e lat e d t o t h e d if f e r e n t ar e as o f e m p lo y m e n t o f t h e In d u s t r ial
Ph ar m ac is t in t h e Ph ar m ac e u t ic al In d u s t r y
Knowledge related to the development, production and distribution of pharmaceutical products.
Un d e r s t an d s t h e d e s ig n , m an u f ac t u r e an d p e r f o r m an c e o f d o s ag e f o r m s
an d is ab le t o c r it ic ally ap p r ais e t h e in t e r - r e lat io n s h ip b e t w e e n f o r m u lat io n ,
d r u g d e liv e r y an d t h e r ap e u t ic e f f e c t iv e n e s s .
!
Has an in t e g r at e d v is io n o f t h e r o le o f t h e v ar io u s d is c ip lin e s t h at ar e
in v o lv e d in t h e d e v e lo p m e n t o f a m e d ic in al p r o d u c t .
Un d e r s t an d s t h e q u alit y r e q u ir e m e n t s f o r m an u f ac t u r in g p r o c e d u r e s
f o r p h ar m ac e u t ic al p r o d u c t s o n b o t h s m all an d in d u s t r ial s c ale , in c lu d in g
St an d ar d Op e r at in g Pr o c e d u r e s an d t h e s u p e r v is io n s t an d ar d s n e c e s s ar y t o
ac h ie v e t h e s e q u alit y le v e ls .
Un d e r s t an d s t h e o r g an is at io n an d m o n it o r in g o f t h e d is t r ib u t io n o f
m e d ic in al an d o t h e r h e alt h c ar e p r o d u c t s in c lu d in g t h e r e g u lat io n s r e lat e d
t o p h ar m ac e u t ic al m ar k e t in g .
. . !
Has k n o w le d g e o f t h e p r o d u c t io n , q u alit y as s u r an c e an d ap p lic at io n s o f
b io t e c h n o lo g y , n an o t e c h n o lo g y an d g e n o m ic m e d ic in e s .
Knowledge related to the analysis and quality control of pharmaceutical products.
Un d e r s t an d s t h e m ain s o u r c e s o f ac t iv e d r u g s u b s t an c e an d t h e m aj o r
e x c ip ie n t s an d t h e w ay s in w h ic h t h e y ar e p u r ifl e d , c h ar ac t e r is e d an d
an aly s e d .
Un d e r s t an d s t h e r o le an d ap p r o p r iat e ap p lic at io n o f t h e v ar io u s t e c h n iq u e s
f o r t h e an aly s is o f p h ar m ac e u t ic al p r o d u c t s .
Un d e r s t an d s t h e r o le an d r e s p o n s ib ilit ie s o f t h e Qu alifl e d Pe r s o n
.
Un d e r s t an d s an d c an e x p lain t h e q u alit y s y s t e m s ap p lie d t o p h ar m ac e u t ic al
p ro d u c t s.
10
x PHARMINE Work Party 6 meeBng – Lisbon (Portugal)
Agenda
Thursday 4th March
Un#l 20:00 Par#cipants arrival
20:00 to not-­‐too-­‐late Informal dinner
Friday 5th March
08:15 to 08:30 Par#cipants recep#on at the faculty of Pharmacy
JGM
08:30 to 09:00 Presenta#on of the results from the QA survey included in the WP7 general survey
JGM
09:00 to 09:30 Presenta#on of the new QA survey
JGM
09:30 to 10:30 Discussion of the new QA survey
ALL
10:45 to 11:00 Coffee break
11:00 to 11:30 Presenta#on of internal QA matrix
RL
11:30 to 12:30 12:30 to 13:00 Discussion of the internal QA matrix
ALL
Future steps and mee#ng closure
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Re: PHARMINE WP6 group mee]ng in Lisboa 5th March 2010
Date : Fri, 05 Feb 2010 18:09:32 +0100
De : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Pour : Jose Morais <jagmorais@ff.ul.pt>
Ruddy Verbinnen <[email protected]>, [email protected], Filiz Hincal <[email protected]>, "Prof. Annie Marcincal" <[email protected]­‐lille2.fr>, Peep Veski <[email protected]>, Bart Rombaut <[email protected]>, Afonso Miguel Cavaco <acavaco@ff.ul.pt>, [email protected], Jose Cabrita <jcabrita@ff.ul.pt>, "Castro, Ma]lde" <mcastro@ff.ul.pt>
Copie à : Références <C37521F33700E343BDC27E609A53F604022E7F4B@mail2.ff.ul.pt>
: Dear José,
Very many thanks for that. I will not be able to come to your meeting
unfortunately (important deadline to meet on the 9th.) but Bart should
be able to make it.
Do you have all the data files? (see file attached)
I was thinking that we may have to give you more time at the Catania
PHARMINE meeting to present your interesting results. What do you think?
Best regards,
Jeff
05/02/2010 18:06
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ 11
xi -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : RE: PHARMINE WP6 group mee]ng in Lisboa 5th March 2010
Date : Mon, 8 Feb 2010 15:01:03 -­‐0000
De : José Morais <jagmorais@ff.ul.pt>
Pour : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Références <C37521F33700E343BDC27E609A53F604022E7F4B@mail2.ff.ul.pt> <[email protected]­‐
: nancy.fr>
Dear Jeff
In order to complete our task we need the following surveys which were missing in the
files you transferred from your computer to our flash drive in Brussels
Belarus
Croatia
Ireland
Sweden
Switzerland
Turkey
UK
Ukraine
Other countries that are missing but not mentioned in your list include Austria,
Bosnia, Moldova...
Could you please give an account of the responses and send the missing ones, if they
exist?
Kindest regards
> José
12
xii -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : RE: PHARMINE WP7 survey Manchester undergraduate courses
Date : Mon, 8 Feb 2010 15:47:51 -­‐0000
De : jane <[email protected]>
Pour : 'Jeffrey ATKINSON' <Jeff[email protected]­‐nancy.fr>
Copie 'George Lockwood' <[email protected]>
à : Jeff
Before you input that Manchester has "specialization in the 4th year", could
I point out that Brian is referring to students undertaking two x 10 credit
optional units of their total 120 credits in the 4th year (our credits being
twice those of the rest of Europe)
The current 4th year really nice range of options at Manchester (from which
the student picks two) are as follows:
Cancer biology and therapy
Advanced neuropharmacology
Novel drug delivery systems
Microbial disease and immunization
Multidisciplinary learning in patient safety
Influences on professional practice
Molecular toxicology
So they are not "specializations" as you and I have discussed.
Regards
Jane
-------- Message original -------Sujet :RE: PHARMINE WP7 survey Manchester undergraduate courses
Date :Fri, 5 Feb 2010 13:16:08 +0000
De :Brian Lockwood <[email protected]>
Répondre à :George Lockwood <[email protected]>
Organisation
University of Manchester
:
Pour :Jeffrey ATKINSON <[email protected]>
Copie à :jane <[email protected]>
Références :<[email protected]>
<20090714113320828.00000001252@UNIVERSI-BE4710>
<[email protected]>
Dear Jeff,
I have a-ached extra data in a Word doc, I do not have access to your pdf.
Best wishes,
Brian
Professor Brian Lockwood,
Director of PIAT,
School of Pharmacy & Pharmaceu]cal Sciences,
Stopford Building, Room 2.27
Oxford Road,
Manchester, M13 9PT
UK
13
xiii -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Re: WP7 survey France -­‐ finalisa]on 200110
Date : Thu, 18 Feb 2010 13:23:11 +0100
De : Marcincal Annie <annie.marcincal@univ-­‐lille2.fr>
Pour : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Références <[email protected]­‐nancy.fr>
: Dear Jeff,
I have kept a gap in my programme this week-end and next week to answer to
your comments on the survey.
Since your letter , end of january, have you received an answer from our
colleagues about "internat". If not I shall start with that.
Amitiés
Annie
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : TR: WP7 survey France -­‐ finalisa]on 200110 -­‐ a gentle reminder
Date : Fri, 5 Feb 2010 19:12:44 +0100
De : lacamoire valerie <[email protected]>
Pour : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Copie <jean-­‐[email protected]>, <pierre.tchoreloff@u-­‐
à : psud.fr>
Bonjour Jeffrey
Vous trouverez ci- joint les commentaires que m'a transmis le professeur
Pierre Tchoreloff ainsi que les documents que j'ai pu rassembler pour
répondre à certaines questions relatives à l'industrie pharmaceutique.
Comme indiqué dans le document c'est en tant que membre du conseil central de
la section B de l'ordre que j'ai renseigné quelques réponses dans la première
version de ce questionnaire. Par conséquent vous pouvez donc supprimer toute
la partie relative à mes coordonnées car je ne pense pas adéquate que
j'apparaisse à titre individuel. En revanche, si vous le jugez utile, je
pourrais vérifier si une validation par l'ensemble des conseillers élus de
la section B serait envisageable, qui devrait alors figurer à la place de mon
nom.
De plus, le professeur Pierre Tchoreloff souligne que ce document devrait
être validé par la conférence de doyens.
Nous sommes à votre disposition pour en discuter avec vous, par conférence
téléphonique par exemple, si vous le souhaitez.
Valérie LACAMOIRE
Directeur Affaires réglementaires / Senior Regulatory Affairs Manager
Astellas Pharma SAS
114, rue Victor Hugo
92 686 Levallois-Perret Cedex
tel : +33 1 55 91 75 51 / fax : + 33 1 55 91 75 69
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ 14
xiv -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Re: WP7 survey E/NE Europe 0210
Date : Fri, 19 Feb 2010 12:12:48 +0100
De : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Pour : Daisy Volmer <[email protected]>
Références <[email protected]­‐nancy.fr> <[email protected]> : <[email protected]­‐nancy.fr> <105d48a7761e2343ff[email protected]>
Dear Daisy,
I was thinking along the lines of:
Bulgaria- BG
Ceska Republika - CZ
*Eesti - EE *
Latvija - LV
*Lithuania - LT *
Magyarorszag - HU
Polska - PL
Rumania- RO
Slovenija -SI
Slovensko -SK
*Suomi - FI *
Sverige - SE
What do you think?
I will be away until the 28/2/2010
Best regards,
Jeff Atkinson
19/02/2010 12:12
_____________________________________________________
Daisy Volmer a écrit :
> Dear prof. Atkinson,
> thank you for the initial info. I will start working on Estonian document
> on Monday. I am afraid I have lost the list of countries, I have to start
> to work with. Would you repeat it for me please!
> Have a nice weekend!
> Daisy
-­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Message original -­‐-­‐-­‐-­‐-­‐-­‐-­‐-­‐ Sujet : Re: WP7 survey document for Estonia as a model for further work 180210
Date : Thu, 18 Feb 2010 18:03:25 +0100
De : Jeffrey ATKINSON <Jeff[email protected]­‐nancy.fr>
Pour : Daisy Volmer <[email protected]>
Copie à : Peep Veski <[email protected]>, Rombaut Bart <[email protected]>, Lea Noel <[email protected]>
Références <[email protected]­‐nancy.fr> : <[email protected]>
Dear Daisy,
Here is the document with comments for Estonia.
The document can serve as an example.
The main things that you would have to do with the replies to the survey
for other countries are:
* to put them in the new format
* to gather supplementary information by
o questions to the author
o research
I suggest you try the Estonia document to get a handle of things. As I
15